Chembio Diagnostics

Chembio Diagnostics Working Capital

Delisted

Working Capital of Chembio Diagnostics (CEMI) as of Nov 21, 2026.

Working Capital

-USD

Last updated:

Working Capital of Chembio Diagnostics is 2026 - USD. Working Capital of Chembio Diagnostics was 2025 32.03 M USD. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Chembio Diagnostics Stock analysis

What does Chembio Diagnostics do? Chembio Diagnostics Inc is a biomedical company specializing in the development and commercialization of diagnostic test kits. The company was founded in 1985 and is headquartered in Medford, New York. Chembio Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Chembio Diagnostics stock

On Eulerpool you can find the complete historical development of Working Capital Chembio Diagnostics since 2006 – with annual values, charts, and detailed analysis.

Working capital is the difference between current assets and current liabilities. Positive working capital indicates a company can meet its short-term obligations.

Working Capital's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Working Capital's Chembio Diagnostics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Chembio Diagnostics

All Key Metrics — Chembio Diagnostics